Drug Shortage Report for OVIDREL
| Report ID | 200401 |
| Drug Identification Number | 02262088 |
| Brand name | OVIDREL |
| Common or Proper name | Choriogonadotropin alfa |
| Company Name | EMD SERONO, A DIVISION OF EMD INC., CANADA |
| Market Status | MARKETED |
| Active Ingredient(s) | CHORIOGONADOTROPIN ALFA |
| Strength(s) | 250MCG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 1 syringe |
| ATC code | G03GA |
| ATC description | GONADOTROPHINS AND OTHER OVULATION STIMULANTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2023-07-28 |
| Estimated end date | 2023-08-08 |
| Actual end date | 2023-08-04 |
| Shortage status | Resolved |
| Updated date | 2023-08-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2695 NORTH SHERIDAN WAY, SUITE 200 MISSISSAUGA, ONTARIO CANADA L5K 2N6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2023-08-05 | English | Compare |
| v6 | 2023-08-04 | French | Compare |
| v5 | 2023-08-04 | English | Compare |
| v4 | 2023-07-29 | English | Compare |
| v3 | 2023-07-28 | French | Compare |
| v2 | 2023-07-28 | French | Compare |
| v1 | 2023-07-28 | English | Compare |
Showing 1 to 7 of 7